Inflammatory Demyelinating Polyneuropathy
📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: IVIG vs SCIG in CIDP [Phase 1]
A Phase 1 clinical trial comparing intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) for chronic inflammatory demyeli…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy [EARLY_Phase 1]
This completed Phase 1 study evaluates the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte p…
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]
A Phase 2 proof-of-concept study of SAR445088 for chronic inflammatory demyelinating polyneuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Two Dose Levels of Privigen in Pediatric CIDP [Phase 4]
A Phase 4 pediatric CIDP trial evaluating two dose levels of Privigen (intravenous immunoglobulin) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.
This clinical trial aims to determine if ultrasound-detected nerve alterations in acute Guillain-Barré syndrome and chronic inflammatory dem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This clinical trials update discusses an Expanded Access IND for Chronic Inflammatory Demyelinating Polyneuropathy. The status indicates the…
-
CLINICAL_TRIALS withdrawal · 2025-09-17Clinical Trial Update: Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]
A Phase 2 trial evaluating Rituximab for chronic inflammatory demyelinating polyneuropathy has been withdrawn.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This study investigates immunoadsorption as a treatment for chronic inflammatory demyelinating polyneuropathy and is currently recruiting, s…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
This clinical trial update describes evaluation of multispectral optoacoustic imaging to detect inflammation and damage in peripheral nerves…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) [Phase 2]
This clinical trial update reports on the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Comparison of FEETME® Soles and GAITRITE® Walkway for the Evaluation of Gait Disorders in CIDP. [NA]
A completed clinical trial comparing FEETME Soles and GAITRITE Walkway for evaluating gait disorders in chronic inflammatory demyelinating p…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Sanofi-sponsored real-world study evaluating treatment outcomes in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is currently rec…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: NT-3 Levels and Function in Individuals With CMT
A clinical trial update examining NT-3 levels and function in individuals with Charcot-Marie-Tooth disease; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BAFF-R CAR-T cell therapy for refractory neuroimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients [Phase 3]
Phase 3 clinical trial evaluating safety and efficacy of different PANZYGA dose regimens in pediatric chronic inflammatory demyelinating pol…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Vitaccess Real CIDP Registry
This entry reports a real-world Vitaccess registry study for chronic inflammatory demyelinating polyneuropathy (CIDP). The study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
The Vanderbilt University Medical Center clinical trial evaluating cutaneous nerve demyelination for diagnosis and treatment of chronic infl…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Biorepository and Registry for Plasma Exchange Patients
A clinical trial update announcing a biorepository and registry for patients undergoing plasma exchange, with recruiting status and listed i…
-
EMA approval · 2025-05-16EMA Authorised: Deqsiga (human normal immunoglobulin) — Takeda Manufacturing Austria AG
EMA authorised Deqsiga, a human normal immunoglobulin product from Takeda Manufacturing Austria AG, for several immunologic and neuropathic …
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial [NA]
This entry reports an active-not-recruiting Mayo Clinic clinical trial assessing the safety of a novel scaffold biomaterial in patients with…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
A clinical trial update for the PolyImPAct study investigating polyneuropathy, impairments, and physical activity, currently recruiting and …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy [Phase 3]
A Phase 3 clinical trial evaluating Ripertamab for chronic inflammatory demyelinating polyneuropathy is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
An exploratory study evaluating the feasibility of predicting decline in chronic inflammatory demyelinating polyneuropathy patients during a…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Quantification of Nerve Stiffness in Neuropathies [NA]
A completed clinical trial update investigating quantification of nerve stiffness in inflammatory neuropathies including Chronic Inflammator…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Hizentra® in Inflammatory Neuropathies - pHeNIx Study
A pHeNIx clinical trial is evaluating Hizentra for Chronic Inflammatory Demyelinating Polyneuropathy and is currently recruiting.